RHHVF
ROCHE HLDG DIV RTSstockOTC
EODNov 17, 2026
472.49USD-2.346%(-11.35)57,686
Loading…
Loading…
331.95B
Healthcare
Drug Manufacturers-General
HQ
Basel, Basel Stadt, Switzerland
103,613
Previous Close
$483.84
Beta
0.39
52-Week High
$499.76 2026-10-30
52-Week Low
$357.30 2026-03-30
SMA 50
$455.38
SMA 200
$432.38
Avg. Vol 10D
12,961
Avg. Vol 30D
5,147
Avg. Vol 90D
5,765
Relative Vol
11.21
702.56M
565.11M
1,005,089
0.18%
433.79
Jan 28, 2027 (70d)
Oct 25, 2026
Oct 16, 2026
Roche's Enspryng wins FDA approval for thyroid eye disease ·
Seeking Alpha
Oct 13, 2026
Oct 11, 2026
Sep 30, 2026
RHHVF Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 484.80 | 2026-11-11 | -2.54% | 0.802 |
| 1M | 458.09 | 2026-10-19 | +3.14% | 0.752 |
| 3M | 444.04 | 2026-08-18 | +6.41% | 0.951 |
| 6M | 407.80 | 2026-05-18 | +15.86% | 0.575 |
| 1Y | 393.87 | 2025-11-18 | +19.96% | 0.393 |
| 2Y | 285.04 | 2024-11-18 | +65.76% | — |
| 5Y | 399.75 | 2021-11-18 | +18.20% | 0.225 |
RHHVF Stock Summary
ROCHE HLDG DIV RTS (OTC:RHHVF) stock price today is $472.49, and today's volume is 57,686. RHHVF is down 2.346% today. The 30 day average volume is 5,147. RHHVF market cap is $331.95B with 702.56M shares outstanding.